The Janus face of dendritic cells in cancer (Q37287170)

19 August 2017

1 reference

title

The Janus face of dendritic cells in cancer (English)

1 reference

19 August 2017

1 reference

5

L Zitvogel

0 references

Nathalie Chaput

1

object named as

N Chaput

0 references

Sophie Viaud

3

object named as

S Viaud

0 references

author name string

R Conforti

2

1 reference

PubMed ID

18836473

19 August 2017

A Spatz

4

1 reference

PubMed ID

18836473

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

5920-5931

1 reference

19 August 2017

45

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.270

19 August 2017

0 references

cites work

Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Involvement of NKR-P2/NKG2D in DC-mediated killing of tumor targets: indicative of a common, innate, target-recognition paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cell infiltration and prognosis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Crosspresentation: plasmacytoid dendritic cells are in the business

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Mechanisms of immune evasion by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Antigen crosspresentation by human plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Virus-stimulated plasmacytoid dendritic cells induce CD4+ cytotoxic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Langerhans cells--revisiting the paradigm using genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cells prime natural killer cells by trans-presenting interleukin 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Natural killer cells and dendritic cells: rendezvous in abused tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Clinical significance of immune cell infiltration within gallbladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen DNTB into an immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

A novel dendritic cell subset involved in tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Experimental and clinical studies of cytokine gene-modified tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Immature CD4- CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

A subset of cytolytic dendritic cells in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cell subsets in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Differential effects of statins on relevant functions of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic and natural killer cells cooperate in the control/switch of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Immunological aspects of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Ready for prime time: NK cell priming by dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cells have the option to express IDO-mediated suppression or not

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

In Vivo Targeting of DC-SIGN-positive Antigen-presenting Cells in a Nonhuman Primate Model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Reciprocal control of T helper cell and dendritic cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Toll-like receptor 3 expressed by melanoma cells as a target for therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

In Melanoma Changes of Immature and Mature Dendritic Cell Expression Correlate with Tumor Thickness: An Immunohistochemical Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Plasmacytoid DCs and T(reg) cells: casual acquaintance or monogamous relationship?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

Impaired function of circulating dendritic cells in patients with pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma--their distribution in relation to prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.270

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2008.270

1 reference

19 August 2017

1 reference

PubMed ID

18836473